Faron Pharmaceuticals Oy (FARN) Competitors GBX 165 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines FARN vs. ERGO, SLN, OXB, PRTC, HZD, VRP, AVCT, ARIX, HVO, and 4BBShould you be buying Faron Pharmaceuticals Oy stock or one of its competitors? The main competitors of Faron Pharmaceuticals Oy include Ergomed (ERGO), Silence Therapeutics (SLN), Oxford Biomedica (OXB), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Avacta Group (AVCT), Arix Bioscience (ARIX), hVIVO (HVO), and 4basebio (4BB). These companies are all part of the "biotechnology" industry. Faron Pharmaceuticals Oy vs. Ergomed Silence Therapeutics Oxford Biomedica PureTech Health Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Avacta Group Arix Bioscience hVIVO 4basebio Faron Pharmaceuticals Oy (LON:FARN) and Ergomed (LON:ERGO) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends. Do insiders & institutionals have more ownership in FARN or ERGO? 10.7% of Faron Pharmaceuticals Oy shares are held by institutional investors. Comparatively, 71.1% of Ergomed shares are held by institutional investors. 31.8% of Faron Pharmaceuticals Oy shares are held by insiders. Comparatively, 18.2% of Ergomed shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community favor FARN or ERGO? Faron Pharmaceuticals Oy received 75 more outperform votes than Ergomed when rated by MarketBeat users. Likewise, 77.51% of users gave Faron Pharmaceuticals Oy an outperform vote while only 75.63% of users gave Ergomed an outperform vote. CompanyUnderperformOutperformFaron Pharmaceuticals OyOutperform Votes31777.51% Underperform Votes9222.49% ErgomedOutperform Votes24275.63% Underperform Votes7824.38% Does the media refer more to FARN or ERGO? In the previous week, Faron Pharmaceuticals Oy's average media sentiment score of 0.00 equaled Ergomed'saverage media sentiment score. Company Overall Sentiment Faron Pharmaceuticals Oy Neutral Ergomed Neutral Do analysts prefer FARN or ERGO? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Faron Pharmaceuticals Oy 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AErgomed 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has stronger earnings & valuation, FARN or ERGO? Ergomed has higher revenue and earnings than Faron Pharmaceuticals Oy. Faron Pharmaceuticals Oy is trading at a lower price-to-earnings ratio than Ergomed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFaron Pharmaceuticals Oy-£725K-238.10-£31.61M-£0.32-515.63Ergomed£152.09M4.61£15M£0.294,641.38 Is FARN or ERGO more profitable? Ergomed has a net margin of 9.87% compared to Faron Pharmaceuticals Oy's net margin of 0.00%. Ergomed's return on equity of 18.08% beat Faron Pharmaceuticals Oy's return on equity.Company Net Margins Return on Equity Return on Assets Faron Pharmaceuticals OyN/A N/A -70.00% Ergomed 9.87%18.08%10.16% Which has more risk & volatility, FARN or ERGO? Faron Pharmaceuticals Oy has a beta of 0.36, suggesting that its stock price is 64% less volatile than the S&P 500. Comparatively, Ergomed has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500. SummaryErgomed beats Faron Pharmaceuticals Oy on 10 of the 13 factors compared between the two stocks. Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. Get Faron Pharmaceuticals Oy News Delivered to You Automatically Sign up to receive the latest news and ratings for FARN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FARN vs. The Competition Export to ExcelMetricFaron Pharmaceuticals OyBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£172.62M£159.96M£5.40B£1.59BDividend YieldN/A3.39%5.13%11.05%P/E Ratio-515.63348.23113.461,740.37Price / Sales-238.1019,593.141,484.40230,520.65Price / Cash20.0011.1439.6435.87Price / Book165.007.754.652.88Net Income-£31.61M-£18.69M£119.06M£144.83M7 Day Performance-8.33%0.01%0.79%0.11%1 Month Performance-25.71%2.54%5.65%-0.11%1 Year Performance-38.20%27.91%36.76%15.28% Faron Pharmaceuticals Oy Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FARNFaron Pharmaceuticals OyN/AGBX 165flatN/A-34.4%£172.62M£-725,000.00-515.6334Gap DownERGOErgomedN/AGBX 1,346flatN/A+0.2%£701.00M£152.09M4,641.386SLNSilence TherapeuticsN/AGBX 535-0.9%N/A+0.0%£480.35M£11.35M-11.01100Positive NewsHigh Trading VolumeOXBOxford Biomedica0.6228 of 5 starsGBX 416-2.0%GBX 433.33+4.2%+96.8%£438.30M£97.28M-288.89891News CoveragePRTCPureTech HealthN/AGBX 155.20+1.8%N/A+4.0%£371.58M£3.33M-674.78300Gap UpHZDHorizon Discovery Group plc (HZD.L)N/AGBX 184.50flatN/A+0.0%£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AGBX 55+5.8%N/A+0.0%£228MN/A-1.6822News CoverageGap UpAVCTAvacta GroupN/AGBX 55.67+0.3%N/A-62.2%£199.48M£22.62M-618.59120ARIXArix BioscienceN/AGBX 142flatN/A+21.9%£183.73M£14.16M1,290.919HVOhVIVON/AGBX 26.60+0.4%N/A+45.3%£180.98M£67.21M886.67N/APositive News4BB4basebioN/AGBX 1,285-4.8%N/A+158.0%£164.61M£311,000.00-1,647.44101News Coverage Related Companies and Tools Related Companies Ergomed Alternatives Silence Therapeutics Alternatives Oxford Biomedica Alternatives PureTech Health Alternatives Horizon Discovery Group plc (HZD.L) Alternatives Verona Pharma plc (VRP.L) Alternatives Avacta Group Alternatives Arix Bioscience Alternatives hVIVO Alternatives 4basebio Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:FARN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Faron Pharmaceuticals Oy Please log in to your account or sign up in order to add this asset to your watchlist. Share Faron Pharmaceuticals Oy With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
